| RS2131776130 |
DCLRE1C
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS2131776376 |
CHST3
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS2131776422 |
DCLRE1C
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS2131776450 |
CHST3
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS2131776743 |
DCLRE1C
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Histiocytic medullary reticulosis |
| RS2131778479 |
DCLRE1C
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS2131778656 |
DCLRE1C
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS2131785934 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131786060 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS2131786241 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131786544 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131791254 |
LGI3
|
Health Risk |
Pathogenic |
Peripheral nerve hyperexcitability syndrome, Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects |
| RS2131791567 |
LGI3
|
Health Risk |
Pathogenic |
Peripheral nerve hyperexcitability syndrome, Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects |
| RS2131791741 |
LGI3
|
Health Risk |
Pathogenic |
Peripheral nerve hyperexcitability syndrome, Peripheral nerve hyperexcitability syndrome |
| RS2131792567 |
MINPP1
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia, type 16 |
| RS2131793302 |
MINPP1
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia, type 16 |
| RS2131795370 |
DOCK8
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS2131796660 |
SLC29A3
|
Health Risk |
Pathogenic |
H syndrome, H syndrome |
| RS2131796689 |
LGI3
|
Health Risk |
Pathogenic |
Peripheral nerve hyperexcitability syndrome, Peripheral nerve hyperexcitability syndrome |
| RS2131797156 |
SLC29A3
|
Health Risk |
Pathogenic |
H syndrome, H syndrome |
| RS2131803905 |
C5
|
Health Risk |
Pathogenic |
— |
| RS2131806725 |
TSC1
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS2131807821 |
TSC1
|
Health Risk |
Pathogenic |
— |
| RS2131808768 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Metaphyseal chondrodysplasia |
| RS2131809131 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131809417 |
RMRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Anauxetic dysplasia, Metaphyseal chondrodysplasia |
| RS2131809449 |
RMRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Anauxetic dysplasia, Metaphyseal chondrodysplasia |
| RS2131809458 |
RMRP
|
Health Risk |
Likely pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2131809467 |
RMRP
|
Health Risk |
Likely pathogenic |
Anauxetic dysplasia, Metaphyseal chondrodysplasia |
| RS2131809514 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2131809584 |
RMRP
|
Health Risk |
Likely pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2131809702 |
RMRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2131809737 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2131809742 |
RMRP
|
Health Risk |
Likely pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2131809743 |
ZMYND11
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS2131809783 |
RMRP
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS2131809894 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2131809930 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2131809964 |
RMRP
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS2131809978 |
RMRP
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS2131810104 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2131810166 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2131810269 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2131810278 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2131810342 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2131810674 |
ZMYND11
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS2131811032 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131811653 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131812351 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131813354 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131814069 |
DOCK8
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS2131814973 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131815084 |
MINPP1
|
Health Risk |
Pathogenic |
Pontoneocerebellar hypoplasia, Pontoneocerebellar hypoplasia |
| RS2131815446 |
SFTPC
|
Health Risk |
Likely pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS2131816800 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131816806 |
SFTPC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pulmonary alveolar proteinosis, Hereditary pulmonary alveolar proteinosis |
| RS2131817146 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131817329 |
SFTPC
|
Health Risk |
Likely pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS2131818738 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131819081 |
SFTPC
|
Health Risk |
Pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS2131820258 |
DNAJC12
|
Health Risk |
Likely pathogenic |
— |
| RS2131820351 |
DNAJC12
|
Health Risk |
Likely pathogenic |
— |
| RS2131820356 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 1 |
| RS2131820786 |
CUBN
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome type 1, Imerslund-Grasbeck syndrome type 1 |
| RS2131820994 |
SFTPC
|
Health Risk |
Likely pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS2131821679 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131821838 |
TSC1
|
Health Risk |
Pathogenic |
— |
| RS2131822866 |
TSC1
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131823012 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131827015 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131830295 |
BMP1
|
Health Risk |
Pathogenic |
— |
| RS2131832036 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131833003 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131839011 |
SLC29A3
|
Health Risk |
Pathogenic |
H syndrome, H syndrome |
| RS2131841336 |
TSC1
|
Health Risk |
Likely pathogenic |
— |
| RS2131842617 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS2131843217 |
TSC1
|
Health Risk |
Pathogenic |
— |
| RS2131843731 |
TPM2
|
Health Risk |
Likely pathogenic |
Congenital myopathy 23, Congenital myopathy 23 |
| RS2131844654 |
CUBN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS2131844956 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131845016 |
CUBN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome type 1, Proteinuria |
| RS2131847938 |
ELN
|
Health Risk |
Pathogenic/Likely pathogenic |
Supravalvar aortic stenosis, Cutis laxa |
| RS2131850310 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131851477 |
SLC29A3
|
Health Risk |
Pathogenic |
H syndrome, H syndrome |
| RS2131851851 |
SPTAN1
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2131851980 |
TPM2
|
Health Risk |
Likely pathogenic |
Arthrogryposis, distal |
| RS2131852702 |
TPM2
|
Health Risk |
Pathogenic |
Arthrogryposis, distal |
| RS2131853219 |
TPM2
|
Health Risk |
Likely pathogenic |
Arthrogryposis, distal |
| RS2131855526 |
BMP1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 13, Osteogenesis imperfecta type 13 |
| RS2131856285 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS2131858633 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS2131863156 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis syndrome |
| RS2131863384 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131863502 |
TRPM3
|
Health Risk |
Likely pathogenic |
— |
| RS2131863686 |
CUBN
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS2131863747 |
TRPM3
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with hypotonia, dysmorphic facies |
| RS2131865150 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131869276 |
ASS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrullinemia type I, Citrullinemia |
| RS2131869283 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2131869439 |
CUBN
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |